Clinical Trial Update: Study to Assess the Effect of Zinc in Atorvastatin Treated Hyperlipidemic Patients [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the effect of zinc in patients with hyperlipidemia treated with atorvastatin is ongoing, with status currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperlipidemias

Drugs mentioned

• ZINC (Zinc chloride)
• atorvastatin (atorvastatin)

Snippet

Sponsor: Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh | Conditions: Hyperlipidemias | Phase 2 | Status: UNKNOWN